Evaluation of Gynecologic Cancer with MR Imaging, 18F-FDG PET/CT, and PET/MR Imaging

Journal of Nuclear Medicine

Onofrio A. Catalano¹  Susanna I. Lee¹  Farrokh Dehdashti¹ 

关键词: Cu-labeled diacetyl-bis (N4-methylthiosemicarbazone) PET;    16α-¹⁸F-fluoro-17β-estradiol PET;    diffusion weighted imaging;    dynamic contrast enhanced MRI;    perfusion MRI;   

DOI  :  10.2967/jnumed.114.145011

学科分类：医学（综合）

来源: Society of Nuclear Medicine

【 摘 要 】

MR imaging and 18F-FDG PET/CT play central and complementary roles in the care of patients with gynecologic cancer. Because treatment often requires combinations of surgery, radiotherapy, and chemotherapy, imaging is central to triage and to determining prognosis. This article reviews the use of the 2 imaging modalities in the initial evaluation of 3 common cancers: uterine cervical, uterine endometrial, and epithelial ovarian. Imaging features that affect management are highlighted, as well as the relative strengths and weaknesses of the 2 modalities. Use of imaging after initial therapy to assess for recurrence and to plan salvage therapy is described. Newer functional and molecular techniques in MR imaging and PET are evaluated. Finally, we describe our initial experience with PET/MR imaging, an emerging technology that may prove to be a mainstay in personalized gynecologic cancer care.

【 授权许可】

Unknown